Shares of Ocugen Inc. OCGN shed 5.16% to $0.83 Wednesday, on what proved to be an all-around positive trading session for the ...

ArMaDa clinical trial is set to assess the safety and efficacy of unilateral subretinal administration of OCU410 in patients ...

Ocugen Inc (OCGN) stock saw a modest uptick, ending the day at $0.9 which represents a slight increase of $0.09 or 11.11% from the prior close of $0.81. The stock opened at $0.87 and touched a low of ...

Maxim Group has recently initiated Ocugen Inc (OCGN) stock to Buy rating, as announced on October 15, 2024, according to Finviz. Earlier, on March 1, 2023, Chardan Capital Markets had raised the stock ...

Dec. 19, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies ...

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410 ...

Maxim Group analyst Michael Okunewitch maintained a Buy rating on Lineage Therap (LCTX – Research Report) yesterday. The company’s shares ...

Ocugen Inc. closed $1.23 below its 52-week high ($2.11), which the company reached on March 25th.

This transaction increased State Street Corp's total holdings in Ocugen to 15,824,517 shares, marking a notable expansion in their investment in the biotech sector. State Street Corp ...

It is a good idea to keep an eye on five biotech breakthrough stocks, MDMD, BEAM, ACLX, OCGN and INSM, as they may give great returns in the next 2-3 years OCU410 has a very favorable safety and ...

MALVERN, Pa., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and ...

It is a good idea to keep an eye on five biotech breakthrough stocks, MDMD, BEAM, ACLX, OCGN and INSM, as they may give great returns in the next 2-3 years OCU410 has a very favorable safety and ...